首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 生物科技 > 生物材料 > 亞太地區整形外科用生物材料市場：2009年
產業/市場分類
生物科技 (1470)
分子標靶治療學 (51)
生技設備 (321)
生物材料 (55)
生物標記 (157)
以基因為基之藥物開發 (201)
再生醫學 (120)
抗體和免疫 (187)
個人化醫學 (54)
基因治療學和RNAi (101)
市場調查報告書

亞太地區整形外科用生物材料市場：2009年

ASIA PACIFIC MARKETS FOR ORTHOPEDIC BIOMATERIALS 2009

出版商 Millennium Research Group
出版日期 2009年10月 商品編碼 102637
內容資訊 英文  
價格
本報告書已不再販售

本報告已在2011年12月29日停止出版。

更改為出版

亞洲的整形外科生醫材料市場:2012年
Asia Pacific Markets for Orthopedic Biomaterials
出版日期 : 2011年12月
商品編碼: 227375

簡介

本報告書內容包括：整形外科用生物材料背景及亞太地區市場概要、玻尿酸黏性補給、骨移植片替代等市場概要、市場預測、促進及抑制因素、該地區的國別市場分析等。內容綱要摘記如下：

實施概要

方法論

第1章　整形外科用生物材料背景

  • 關節炎及玻尿酸黏性補給概要
    • 變異性關節炎
    • 慢性關節炎
    • 替代治療方法
  • 骨移植片概要
    • 自體移植片
    • 一般用同類移植片
    • 脫鹽骨基質（DBM）
    • 合成骨移植材料
    • 成長要素
    • 骨移植片替代應用

第2章　亞太地區整形外科用生物材料市場

  • 市場概要
  • 市場分析
    • 主要新調查内容
    • 預測期間的經濟前提條件
    • 處置
    • 市場預測
  • 競爭分析

第3章　玻尿酸黏性補給市場

  • 市場概要
  • 市場分析
    • 處置
    • 市場預測
    • 市場發展的促進及限制因素
  • 競爭分析

第4章　骨移植片替代市場

  • 市場概要
  • 市場分析
    • 處置
    • 市場預測
    • 市場發展的促進及限制因素
  • 競爭分析

附錄

圖表一覽

目錄

Abstract

The market for Asia Pacific orthopedic biomaterials will be primarily driven by the region' s aging population that requires greater care and maintenance of their bones and joints. The hyaluronic acid viscosupplementation segment will be favorably affected by both the aging and physically active demographics, as well as rising awareness of the treatment' s benefits among physicians and patients. The market will, however, be limited by price competition and reimbursement challenges. Some of the countries in this market will experience reimbursement cuts for HA viscosupplementation treatments, while these treatments are not covered at all in other countries. The bone graft substitute (BGS) market will be fueled by increasing surgeon and patient awareness of the advantages of these materials over autografts. In addition, the introduction of bone morphogenetic proteins (BMPs) into the South Korean market will cause a surge in revenues; however, strong cost-consciousness among Asia Pacific hospitals will continue to hinder the growth of this market.

Table of Contents

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 ORTHOPEDIC BIOMATERIALS BACKGROUND

  • 1.1 Arthritis and Hyaluronic Acid Viscosupplementation Overview
    • 1.1.1 Osteoarthritis
    • 1.1.2 Rheumatoid Arthritis
    • 1.1.3 Treatment Alternatives
      • 1.1.3.1 Nonpharmacologic Treatments
      • 1.1.3.2 Nonsteroidal Anti - Inflammatory Drugs
      • 1.1.3.3 Cyclooxygenase - 2 Inhibitors
      • 1.1.3.4 Hyaluronic Acid Viscosupplementation
  • 1.2 Bone Graft Overview
    • 1.2.1 Autografts
    • 1.2.2 Nonproprietary Allografts
    • 1.2.3 Demineralized Bone Matrices
    • 1.2.4 Synthetics
    • 1.2.5 Growth Factors
    • 1.2.6 Bone Graft Substitute Applications
      • 1.2.6.1 Trauma Surgery
      • 1.2.6.2 Spinal Fusion
      • 1.2.6.3 Joint Revision and Replacement
      • 1.2.6.4 Craniomaxillofacial Surgery

2.0 ASIA PACIFIC ORTHOPEDIC BIOMATERIAL MARKET

  • 2.1 Market Overview
  • 2.2 Market Analysis
    • 2.2.1 Key Report Updates
    • 2.2.2 Economic Assumptions for the Forecast Period
    • 2.2.3 Procedures
      • 2.2.3.1 Hyaluronic Acid Viscosupplementation Procedures
    • 2.2.3.2 Bone Graft Procedures
    • 2.2.4 Market Forecast
      • 2.2.4.1 Hyaluronic Acid Viscosupplementation Market
      • 2.2.4.2 Bone Graft Substitute Market
    • 2.3 Competitive Analysis
  • 2.3.1 Market Shares

3.0 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 3.1 Market Overview
  • 3.2 Market Analysis
    • 3.2.1 Procedures
      • 3.2.1.1 Asia Pacific Hyaluronic Acid Viscosupplementation Procedures
      • 3.2.1.2 Australian Hyaluronic Acid Viscosupplementation Procedures
      • 3.2.1.3 Chinese Hyaluronic Acid Viscosupplementation Procedures
        • Mainland Chinese Hyaluronic Acid Viscosupplementation Procedures
        • Hong Kong Hyaluronic Acid Viscosupplementation Procedures
      • 3.2.1.4 Japanese Hyaluronic Acid Viscosupplementation Procedures
      • 3.2.1.5 South Korean Hyaluronic Acid Viscosupplementation Procedures
      • 3.2.1.6 Taiwanese Hyaluronic Acid Viscosupplementation Procedures
    • 3.2.2 Market Forecast
      • 3.2.2.1 Asia Pacific Hyaluronic Acid Viscosupplementation Market
      • 3.2.2.2 Australian Hyaluronic Acid Viscosupplementation Market
      • 3.2.2.3 Chinese Hyaluronic Viscosupplementation Market
        • Mainland Chinese Hyaluronic Viscosupplementation Market
        • Hong Kong Hyaluronic Viscosupplementation Market
      • 3.2.2.4 Japanese Hyaluronic Acid Viscosupplementation Market
      • 3.2.2.5 South Korean Hyaluronic Acid Viscosupplementation Market
      • 3.2.2.6 Taiwanese Hyaluronic Acid Viscosupplementation Market
    • 3.2.3 Market Drivers and Limiters
      • 3.2.3.1 Market Drivers
      • 3.2.3.2 Market Limiters
  • 3.3 Competitive Analysis
    • 3.3.1 Competitive Landscape
    • 3.3.2 Market Shares
    • 3.3.3 Competitor Discussions (in Alphabetical Order)
      • Chugai Pharmaceutical
      • Genzyme
      • Maruho
      • Seikagaku
      • Shandong Bausch Lomb Freda Pharmaceutical
      • Other

4.0 BONE GRAFT SUBSTITUTE MARKET

  • 4.1 Market Overview
  • 4.2 Market Analysis
    • 4.2.1 Procedures
      • 4.2.1.1 Asia Pacific Bone Graft Procedures
        • By Country
        • By Material
        • By Application
      • 4.2.1.2 Australian Bone Graft Procedures
        • Bone Graft Procedures, by Material
        • Bone Graft Substitute Procedures, by Application
      • 4.2.1.3 Japanese Bone Graft Procedures
        • Bone Graft Procedures, by Material
        • Bone Graft Substitute Procedures, by Application
      • 4.2.1.4 South Korean Bone Graft Procedures
        • Bone Graft Procedures, by Material
        • Bone Graft Substitute Procedures, by Application
    • 4.2.2 Market Forecast
      • 4.2.2.1 Asia Pacific Bone Graft Substitute Market
      • 4.2.2.2 Australian Bone Graft Substitute Market
      • 4.2.2.3 Japanese Bone Graft Substitute Market
      • 4.2.2.4 South Korean Bone Graft Substitute Market
    • 4.2.3 Market Drivers and Limiters
      • 4.2.3.1 Market Drivers
      • 4.2.3.2 Market Limiters
  • 4.3 Competitive Analysis
  • 4.3.1 Competitive Landscape
  • 4.3.2 Market Shares
  • 4.3.3 Competitor Discussions (in Alphabetical Order)
    • BioImTech
    • DePuy Spine
    • GS Medical
    • Kobayashi Pharmaceutical
    • Korea Bone Bank
    • Medtronic Spinal & Biologics
    • Olympus Terumo Biomaterials
    • PENTAX
    • Stryker
    • Synthes
    • Other

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: ASIA PACIFIC POPULATION STATISTICS

APPENDIX C: OSTEOARTHRITIS EPIDEMIOLOGY

APPENDIX D: OSTEOPOROSIS EPIDEMIOLOGY

APPENDIX E: SUPPLEMENTAL EXHIBITS

List of Exhibits

EXECUTIVE SUMMARY

  • Exhibit 1: Orthopedic Biomaterial Market, by Segment, Asia Pacific (US$), 2007 - 2013
  • Exhibit 2: HA Viscosupplementation Market, by Injection, Asia Pacific (US$), 2007 - 2013
  • Exhibit 3: BGS Procedures, by Type, as a % of Total, Asia Pacific, 2007 - 2013 XIII
  • Exhibit 4: Leading Competitors in the Orthopedic Biomaterial Market, Asia Pacific, 2008 XIV

METHODOLOGY

  • Exhibit 5: Currency Exchange Rates, 2008XVII

CHAPTER 1: ORTHOPEDIC BIOMATERIALS BACKGROUND

  • Exhibit 6: Select HA Viscosupplementation Companies and Products, Asia Pacific, 2008
  • Exhibit 7: Characteristics of Bone Graft Materials
  • Exhibit 8: Advantages and Disadvantages of Various Bone Graft Materials
  • Exhibit 9: Select Synthetic BGS

CHAPTER 2: ASIA PACIFIC ORTHOPEDIC BIOMATERIAL MARKET

  • Exhibit 10: Orthopedic Biomaterial Market, by Segment, Asia Pacific (US$), 2007 - 2013
  • Exhibit 11: Key Report Updates, 2009
  • Exhibit 12: Orthopedic Biomaterial Market, by Segment, Asia Pacific (US$), 2007 - 2013 (Tabular Format)
  • Exhibit 13: HA Viscosupplementation Market, by Country, Asia Pacific (US$), 2007 - 2013
  • Exhibit 14: BGS Market, by Country, Asia Pacific (US$), 2007 - 2013
  • Exhibit 15: Leading Competitors in the Orthopedic Biomaterial Market, as a % of Total, Asia Pacific, 2008
  • Exhibit 16: Leading Competitors in the Orthopedic Biomaterial Market, by Segment, as a % of Total, Asia Pacific, 2008

CHAPTER 3: HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Exhibit 17: HA Viscosupplementation Market, Asia Pacific (US$), 2007 - 2013
  • Exhibit 18: HA Viscosupplementation Treatments, by Country, Asia Pacific, 2007 - 2013
  • Exhibit 19: HA Viscosupplementation Treatments and Injection, by Segment, Asia Pacific, 2007 - 2013
  • Exhibit 20: HA Viscosupplementation Treatments, by Application, Asia Pacific, 2007 - 2013
  • Exhibit 21: HA Viscosupplementation Treatments and Injection, by Segment, Australia, 2007 - 2013
  • Exhibit 22: HA Viscosupplementation Treatments, by Application, Australia, 2007 - 2013
  • Exhibit 23: HA Viscosupplementation Treatments, Mainland China and Hong Kong, 2007 - 2013
  • Exhibit 24: HA Viscosupplementation Treatments and Injections, by Segment, Mainland China, 2007 - 2013
  • Exhibit 25: HA Viscosupplementation Treatments, by Application, Mainland China, 2007 - 2013
  • Exhibit 26: HA Viscosupplementation Treatments and Injections, by Segment, Japan, 2007 - 2013
  • Exhibit 27: HA Viscosupplementation Treatments, by Application, Japan, 2007 - 2013
  • Exhibit 28: HA Viscosupplementation Treatments, by Type, Japan, 2007 - 2013
  • Exhibit 29: HA Viscosupplementation Treatments and Injections, by Segment, South Korea, 2007 - 2013
  • Exhibit 30: HA Viscosupplementation Treatments, by Application, South Korea, 2007 - 2013
  • Exhibit 31: HA Viscosupplementation Treatments and Injections, by Segment, Taiwan, 2007 - 2013
  • Exhibit 32: HA Viscosupplementation Treatments, by Application, Taiwan, 2007 - 2013
  • Exhibit 33: HA Viscosupplementation Market, by Country, Asia Pacific, 2007 - 2013
  • Exhibit 34: HA Viscosupplementation Market, by Segment, Asia Pacific (US$), 2007 - 2013
  • Exhibit 35: HA Viscosupplementation Market Growth, by Segment, Asia Pacific, 2008 - 2013
  • Exhibit 36: HA Viscosupplementation Market, by Segment, as a % of Total, Asia Pacific, 2007 - 2013
  • Exhibit 37: HA Viscosupplementation Market, by Segment, Australia (US$), 2007 - 2013
  • Exhibit 38: HA Viscosupplementation Market, by Segment, Australia (AU$), 2007 - 2013
  • Exhibit 39: HA Viscosupplementation Market Growth, by Segment, Australia, 2008 - 2013
  • Exhibit 40: HA Viscosupplementation Market, by Segment, as a % of Total, Australia, 2007 - 2013
  • Exhibit 41: HA Viscosupplementation Market, Mainland China and Hong Kong (US$), 2007 - 2013
  • Exhibit 42: HA Viscosupplementation Market, by Segment, Mainland China (US$), 2007 - 2013
  • Exhibit 43: HA Viscosupplementation Market, by Segment, Mainland China (CNY), 2007 - 2013
  • Exhibit 44: HA Viscosupplementation Market Growth, by Segment, Mainland China, 2008 - 2013
  • Exhibit 45: HA Viscosupplementation Market, by Segment, as a % of Total, Mainland China, 2007 - 2013
  • Exhibit 46: HA Viscosupplementation Market, by Segment, Japan (US$), 2007 - 2013
  • Exhibit 47: HA Viscosupplementation Market, by Segment, Japan (¥), 2007 - 2013
  • Exhibit 48: HA Viscosupplementation Market Growth, by Segment, Japan, 2008 - 2013
  • Exhibit 49: HA Viscosupplementation Market, by Segment, as a % of Total, Japan, 2007 - 2013
  • Exhibit 50: HA Viscosupplementation Market, by Type, Japan (US$), 2007 - 2013
  • Exhibit 51: HA Viscosupplementation Market, by Type, Japan (¥), 2007 - 2013
  • Exhibit 52: HA Viscosupplementation Market Growth, by Type, Japan, 2008 - 2013
  • Exhibit 53: HA Viscosupplementation Market, by Type, as a % of Total, Japan, 2007 - 2013
  • Exhibit 54: HA Viscosupplementation Market, by Segment, South Korea (US$), 2007 - 2013
  • Exhibit 55: HA Viscosupplementation Market, by Segment, South Korea (KRW), 2007 - 2013
  • Exhibit 56: HA Viscosupplementation Market Growth, by Segment, South Korea, 2008 - 2013
  • Exhibit 57: HA Viscosupplementation Market, by Segment, as a % of Total, South Korea, 2007 - 2013
  • Exhibit 58: HA Viscosupplementation Market, by Segment, Taiwan (US$), 2007 - 2013
  • Exhibit 59: HA Viscosupplementation Market, by Segment, Taiwan (NT$), 2007 - 2013
  • Exhibit 60: HA Viscosupplementation Market Growth, by Segment, Taiwan, 2008 - 2013
  • Exhibit 61: HA Viscosupplementation Market, by Segment, as a % of Total, Taiwan, 2007 - 2013
  • Exhibit 62: Drivers and Limiters of the HA Viscosupplementation Market, Asia Pacific
  • Exhibit 63: Leading Competitors in the HA Viscosupplementation Market, as a % of Total, Asia Pacific, 2008
  • Exhibit 64: Leading Competitors in the HA Viscosupplementation Market, by Country, as a % of Total, Asia Pacific, 2008

CHAPTER 4: BONE GRAFT SUBSTITUTE MARKET

  • Exhibit 65: BGS Market, by Country, Asia Pacific (US$), 2007 - 2013
  • Exhibit 66: Average Amount of BGS Material Used, by Application, Asia Pacific, 2008
  • Exhibit 67: Bone Graft Procedures, by Country, Asia Pacific, 2007 - 2013
  • Exhibit 68: Bone Graft Procedures, by Material, Asia Pacific, 2007 - 2013
  • Exhibit 69: BGS Procedures, by Country, Asia Pacific, 2007 - 2013
  • Exhibit 70: BGS Procedures, by Application, Asia Pacific, 2007 - 2013
  • Exhibit 71: Bone Graft Procedures, by Material, Australia, 2007 - 2013
  • Exhibit 72: BGS Procedures, by Application, Australia, 2007 - 2013
  • Exhibit 73: Bone Graft Procedures, by Material, Japan, 2007 - 2013
  • Exhibit 74: BGS Procedures, by Application, Japan, 2007 - 2013
  • Exhibit 75: Bone Graft Procedures, by Material, South Korea, 2007 - 2013
  • Exhibit 76: BGS Procedures, by Application, South Korea, 2007 - 2013
  • Exhibit 77: BGS Market, by Country, Asia Pacific (US$), 2007 - 2013
  • Exhibit 78: BGS Market, by Material, Asia Pacific (US$), 2007 - 2013
  • Exhibit 79: BGS Market, by Application, Asia Pacific (US$), 2007 - 2013
  • Exhibit 80: BGS Market, by Material, Australia (US$), 2007 - 2013
  • Exhibit 81: BGS Market, by Material, Australia (AU$), 2007 - 2013
  • Exhibit 82: BGS Market Growth, by Material, Australia, 2008 - 2013
  • Exhibit 83: BGS Market, by Material, as a % of Total, Australia, 2007 - 2013
  • Exhibit 84: BGS Market, by Application, Australia (US$), 2007 - 2013
  • Exhibit 85: BGS Market, by Application, Australia (AU$), 2007 - 2013
  • Exhibit 86: Spinal Fusion BGS Market, Australia (US$ and AU$), 2007 - 2013
  • Exhibit 87: Trauma Surgery BGS Market, Australia (US$ and AU$), 2007 - 2013
  • Exhibit 88: Joint Revision and Reconstruction BGS Market, Australia (US$ and AU$), 2007 - 2013
  • Exhibit 89: CMF Surgery BGS Market, Australia (US$ and AU$), 2007 - 2013
  • Exhibit 90: BGS Market, by Application, Japan (US$), 2007 - 2013
  • Exhibit 91: BGS Market, by Application, Japan (¥), 2007 - 2013
  • Exhibit 92: Spinal Fusion BGS Market, Japan (US$ and ¥), 2007 - 2013
  • Exhibit 93: Trauma Surgery BGS Market, Japan (US$ and ¥), 2007 - 2013
  • Exhibit 94: Joint Revision and Reconstruction BGS Market, Japan (US$ and ¥), 2007 - 2013
  • Exhibit 95: CMF Surgery BGS Market, Japan (US$ and ¥), 2007 - 2013
  • Exhibit 96: BGS Market, by Material, South Korea (US$), 2007 - 2013
  • Exhibit 97: BGS Market, by Material, South Korea (KRW), 2007 - 2013
  • Exhibit 98: BGS Market Growth, by Material, South Korea, 2008 - 2013
  • Exhibit 99: BGS Market, by Material, as a % of Total, South Korea, 2007 - 2013
  • Exhibit 100: BGS Market, by Application, South Korea (US$), 2007 - 2013
  • Exhibit 101: BGS Market, by Application, South Korea (W), 2007 - 2013
  • Exhibit 102: Spinal Fusion BGS Market, South Korea (US$ and W), 2007 - 2013
  • Exhibit 103: Trauma Surgery BGS Market, South Korea (US$ and W), 2007 - 2013
  • Exhibit 104: Joint Revision and Reconstruction BGS Market, South Korea (US$ and W), 2007 - 2013
  • Exhibit 105: CMF Surgery BGS Market, South Korea (US$ and W), 2007 - 2013
  • Exhibit 106: Drivers and Limiters of the BGS Market, Asia Pacific
  • Exhibit 107: Leading Competitors in the BGS Market, as a % of Total, Asia Pacific, 2008
  • Exhibit 108: Leading Competitors in the BGS Market, by Country, as a % of Total, Asia Pacific, 2008

APPENDIX B: ASIA PACIFIC POPULATION STATISTICS

  • Exhibit 109: Population, Australia, 2008 - 2013
  • Exhibit 110: Population, China, 2008 - 2013
  • Exhibit 111: Population, Japan, 2008 - 2013
  • Exhibit 112: Population, South Korea, 2008 - 2013

APPENDIX C: OSTEOARTHRITIS EPIDEMIOLOGY

  • Exhibit 113: Prevalence of Osteoarthritis, Japan, 2008 - 2013

APPENDIX D: OSTEOPOROSIS EPIDEMIOLOGY

  • Exhibit 114: Prevalence of Osteoporosis, Japan, 2008 - 2013

APPENDIX E: SUPPLEMENTAL EXHIBITS

  • Exhibit 115: Orthopedic Biomaterial Market, by Segment, Asia Pacific (US$), 2007 - 2013 (Detailed Format)
  • Exhibit 116: HA Viscosupplementation Market, by Injection, Asia Pacific (US$), 2007 - 2013 (Detailed Format)
  • Exhibit 117: BGS Procedures, by Type, as a % of Total, Asia Pacific, 2007 - 2013 (Detailed Format)
Back to Top